Skip to main content

Expert opinion

Neuer Inhalt Free Registration

Gain full access to the latest clinical content available from Springer Nature

From the Editorial Board

08-22-2017 | Retinopathy | Editorial | Article

Antivascular endothelial growth factor treatment for proliferative diabetic retinopathy: Perspective on the CLARITY study

In this editorial, Rishi Singh and colleagues provide their perspective on the future of proliferative diabetic retinopathy treatment following the completion of the CLARITY and Protocol S studies.

Nathaniel B. Rieveschl, Felipe F. Conti, Rishi P. Singh

07-05-2017 | Prevention | Editorial | Article

Type 2 diabetes can be prevented in your patients

Editorial Board member Jay Shubrook and his colleague Alegria Cantillep discuss the National Diabetes Prevention Program, how you might find eligible patients, and how you can refer them to the program.

Alegria Cantillep, Jay Shubrook DO

06-13-2017 | Type 2 diabetes | Editorial | Article

Is it harder to treat diabetes today?

Treating type 2 diabetes has become so complicated. Why is this so? Editorial Board member Jay Shubrook discusses the reasons and suggests ways to make diabetes treatment less overwhelming.

Jay Shubrook DO

05-08-2017 | Metformin | Editorial | Article

Metformin: What is new with this old medication?

With the arrival of slow-release formulations of metformin and the relaxation of guidelines concerning its use in patients with kidney disease, Carol Wysham explains how the population of patients who might benefit from this medication has expanded.

Carol Wysham MD

01-13-2017 | Cardiovascular outcomes | Editorial | Article

Clinical implications of cardiovascular outcomes trials in type 2 diabetes

What do the results of CVOTs mean for practicing clinicians? Editorial board member Carol Hatch Wysham reviews the latest evidence and guidelines for reducing CV risk in patients with type 2 diabetes.

Carol Wysham MD

12-19-2016 | Editorial | Article

Progress in diabetes care: looking back at 2016

As 2016 draws to a close, our editorial board members reflect on the key advances in understanding and treating diabetes over the past year, and give their thoughts on the research to watch out for in 2017.

Sanjay Kalra MBBS, MD, DM , Lori Berard RN CDE, Jay Shubrook DO, John Wilding DM FRCP

12-15-2016 | Guidelines | Editorial | Article

What is new in the 2017 American Diabetes Association Standards of Care?

Jay Shubrook, Chair of the American Diabetes Association’s Primary Care Advisory Group, outlines what's new in this year's ADA Standards of Care update. 

Jay Shubrook DO

11-25-2016 | Devices and technology | Editorial | Article

Choosing an insulin delivery device

A process of shared and informed decision-making, facilitated by demonstration, helps ensure that the right delivery device is chosen and prescribed for persons who require insulin.

Sanjay Kalra MBBS, MD, DM

11-11-2016 | Editorial | Article

World Diabetes Day, November 14 2016

A call to action from editorial board member Lori Berard.

Lori Berard RN CDE

11-04-2016 | Editorial | Article

My EASD 2016 Highlights: From Paleolithic diets to the artificial pancreas

Editorial board member John Wilding outlines key moments from the 52nd annual meeting of the European Association for the Study of Diabetes in Munich, Germany.

John Wilding DM FRCP

10-24-2016 | Hypoglycemia | Editorial | Article

Attention to hypoglycemia can improve glucose control and reduce risk

Jay Shubrook explores why it is so important to include the assessment and management of hypoglycemia as part of your diabetes management plan.

Jay Shubrook DO

Meet our Editorial Board

Lori BerardSanjay KalraJay ShubrookProfessor John WildingCarol Wysham

New Content Item Meet our Advisory Board

image credits